An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
- Sponsor
- Marcus Powlowski
- Introduced
- —
- Royal assent
- —
- Final vote
- —
Legislative timeline
- 1stMar 11, 2026
- 2ndJun 10, 2026
- Comm.—
- 3rd—
- Senate—
- Assent—
Bill overview
Bill C-265, “An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)”, is a federal bill from session 45-1. It was introduced by Marcus Powlowski (Liberal, Thunder Bay-Rainy River).
It reached first reading on March 11, 2026 and second reading on June 10, 2026. Its latest recorded status is “In committee”.
This overview is written automatically from the registry and vote records on this page and updates when they sync. It describes the bill's path, not its merits.
PLAIN-LANGUAGE SUMMARY
What you need to know
An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
Vote roll
No division has been recorded for this bill yet.